These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8690232)

  • 1. Dapsone toxicity: some current perspectives.
    Coleman MD
    Gen Pharmacol; 1995 Nov; 26(7):1461-7. PubMed ID: 8690232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro.
    Coleman MD; Jacobus DP
    Biochem Pharmacol; 1993 Mar; 45(5):1027-33. PubMed ID: 8461032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro. IV: Implications for the development of agranulocytosis.
    Coleman MD; Simpson J; Jacobus DP
    Biochem Pharmacol; 1994 Oct; 48(7):1349-54. PubMed ID: 7945432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance.
    Coleman MD
    Br J Dermatol; 1993 Nov; 129(5):507-13. PubMed ID: 8251346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.
    Coleman MD; Scott AK; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1990 Nov; 30(5):761-7. PubMed ID: 2271376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro--II. Movement of dapsone across a semipermeable membrane into erythrocytes and plasma.
    Coleman MD; Jacobus DP
    Biochem Pharmacol; 1993 Oct; 46(8):1363-8. PubMed ID: 8240384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients.
    Coleman MD; Rhodes LE; Scott AK; Verbov JL; Friedmann PS; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1992 Sep; 34(3):244-9. PubMed ID: 1389948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Respiratory insufficiency caused by dapsone-induced methemoglobinemia].
    Ipsen SE; Hansen VE
    Ugeskr Laeger; 2001 Jan; 163(1):39-40. PubMed ID: 11586671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapsone and sulfapyridine.
    Paniker U; Levine N
    Dermatol Clin; 2001 Jan; 19(1):79-86, viii. PubMed ID: 11155588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Hydroxylation of dapsone by multiple enzymes of cytochrome P450: implications for inhibition of haemotoxicity.
    Gill HJ; Tingle MD; Park BK
    Br J Clin Pharmacol; 1995 Dec; 40(6):531-8. PubMed ID: 8703658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the metabolism and toxicity of dapsone in rat, mouse and man.
    Tingle MD; Mahmud R; Maggs JL; Pirmohamed M; Park BK
    J Pharmacol Exp Ther; 1997 Nov; 283(2):817-23. PubMed ID: 9353403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtle case of dapsone-induced methaemoglobinaemia.
    Lewis JS; Jacobs ZG
    BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32843412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro. III: Effect of diabetes.
    Coleman MD; Simpson J; Jacobus DP
    Biochem Pharmacol; 1994 Oct; 48(7):1341-7. PubMed ID: 7945431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dapsone-induced blood dyscrasia in the mouse: evidence for the role of an active metabolite.
    Ahmadi M; Khalaf LF; Smith HJ; Nicholls PJ
    J Pharm Pharmacol; 1996 Feb; 48(2):228-32. PubMed ID: 8935178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapsone-induced agranulocytosis-possible involvement of low-activity N-acetyltransferase 2.
    Potočnjak I; Likić R; Šimić I; Juričić Nahal D; Čegec I; Ganoci L; Božina N
    Fundam Clin Pharmacol; 2017 Oct; 31(5):580-586. PubMed ID: 28322460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapsone hydroxylamine induces premature removal of human erythrocytes by membrane reorganization and antibody binding.
    Bordin L; Fiore C; Zen F; Coleman MD; Ragazzi E; Clari G
    Br J Pharmacol; 2010 Nov; 161(5):1186-99. PubMed ID: 20662842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe methemoglobinemia due to topical dapsone misuse in a teenage girl.
    Yale S; Stefanko N; McCarthy P; McFadden V; McCarthy J
    Pediatr Dermatol; 2020 Mar; 37(2):377-378. PubMed ID: 31876314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone.
    Reilly TP; Bellevue FH; Woster PM; Svensson CK
    Biochem Pharmacol; 1998 Mar; 55(6):803-10. PubMed ID: 9586952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cimetidine improves the therapeutic/toxic ratio of dapsone in patients on chronic dapsone therapy.
    Rhodes LE; Tingle MD; Park BK; Chu P; Verbov JL; Friedmann PS
    Br J Dermatol; 1995 Feb; 132(2):257-62. PubMed ID: 7888363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cimetidine and dapsone-mediated methaemoglobinaemia.
    Mehta M
    Anaesthesia; 2007 Nov; 62(11):1188. PubMed ID: 17924910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.